OBJECTIVE: Frame-based stereotactic puncture and catheter placement followed by fibrinolytic therapy and drainage is one treatment option in the management of spontaneous intracerebral hemorrhage (sICH). This minimally invasive procedure could even be simplified by frameless stereotaxy. The authors present their experiences with frameless stereotactic image-guided catheter placement for lysis and drainage of sICH, with emphasis on technical aspects. METHOD: In 27 patients with sICH, an infrared-based frameless stereotactic device was used for selecting trajectory and target point of hematoma drainage. A trajectory along the main axis of the hematoma was considered to be optimal for fibrinolytic therapy. An articulated arm served to maintain the predetermined trajectory during surgery and to guide catheter advancement. Clot lysis with recombinant tissue plasminogen activator (rt-PA) was initiated after radiological confirmation of correct catheter positioning. RESULTS: In all cases, selection of the optimal trajectory was not restricted by the frameless stereotactic device. In 25 of the 27 patients, the catheter was placed accurately along the predetermined trajectory into the target point. In two patients, the catheter was positioned at the lateral margin of the hematoma, excluding fibrinolytic therapy in one case. In 24 of 27 patients, the mean hematoma volume could be reduced from initially 52 ml to 17 ml in an average of two days. Hematoma enlargement following rt-PA injection was observed in two patients. Further complications were culture negative pleocytosis of cerebrospinal fluid in two and meningitis in one patient. CONCLUSION: Hematoma puncture and catheter placement for fibrinolytic therapy could be achieved with high accuracy and safety using frameless stereotaxy. This method allows unrestricted trajectory selection with catheter positioning along the main hematoma axis. Further studies are required to investigate if frameless stereotactic puncture and clot lysis could contribute to improve the outcome of patients with sICH.
OBJECTIVE: Frame-based stereotactic puncture and catheter placement followed by fibrinolytic therapy and drainage is one treatment option in the management of spontaneous intracerebral hemorrhage (sICH). This minimally invasive procedure could even be simplified by frameless stereotaxy. The authors present their experiences with frameless stereotactic image-guided catheter placement for lysis and drainage of sICH, with emphasis on technical aspects. METHOD: In 27 patients with sICH, an infrared-based frameless stereotactic device was used for selecting trajectory and target point of hematoma drainage. A trajectory along the main axis of the hematoma was considered to be optimal for fibrinolytic therapy. An articulated arm served to maintain the predetermined trajectory during surgery and to guide catheter advancement. Clot lysis with recombinant tissue plasminogen activator (rt-PA) was initiated after radiological confirmation of correct catheter positioning. RESULTS: In all cases, selection of the optimal trajectory was not restricted by the frameless stereotactic device. In 25 of the 27 patients, the catheter was placed accurately along the predetermined trajectory into the target point. In two patients, the catheter was positioned at the lateral margin of the hematoma, excluding fibrinolytic therapy in one case. In 24 of 27 patients, the mean hematoma volume could be reduced from initially 52 ml to 17 ml in an average of two days. Hematoma enlargement following rt-PA injection was observed in two patients. Further complications were culture negative pleocytosis of cerebrospinal fluid in two and meningitis in one patient. CONCLUSION:Hematoma puncture and catheter placement for fibrinolytic therapy could be achieved with high accuracy and safety using frameless stereotaxy. This method allows unrestricted trajectory selection with catheter positioning along the main hematoma axis. Further studies are required to investigate if frameless stereotactic puncture and clot lysis could contribute to improve the outcome of patients with sICH.
Authors: Ryan J Barrett; Rahat Hussain; William M Coplin; Samera Berry; Penelope M Keyl; Daniel F Hanley; Robert R Johnson; J Ricardo Carhuapoma Journal: Neurocrit Care Date: 2005 Impact factor: 3.210
Authors: Daniel F Hanley; Richard E Thompson; Michael Rosenblum; Gayane Yenokyan; Karen Lane; Nichol McBee; Steven W Mayo; Amanda J Bistran-Hall; Dheeraj Gandhi; W Andrew Mould; Natalie Ullman; Hasan Ali; J Ricardo Carhuapoma; Carlos S Kase; Kennedy R Lees; Jesse Dawson; Alastair Wilson; Joshua F Betz; Elizabeth A Sugar; Yi Hao; Radhika Avadhani; Jean-Louis Caron; Mark R Harrigan; Andrew P Carlson; Diederik Bulters; David LeDoux; Judy Huang; Cully Cobb; Gaurav Gupta; Ryan Kitagawa; Michael R Chicoine; Hiren Patel; Robert Dodd; Paul J Camarata; Stacey Wolfe; Agnieszka Stadnik; P Lynn Money; Patrick Mitchell; Rosario Sarabia; Sagi Harnof; Pal Barzo; Andreas Unterberg; Jeanne S Teitelbaum; Weimin Wang; Craig S Anderson; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Wendy Ziai; Mario Zuccarello; Issam A Awad Journal: Lancet Date: 2019-02-07 Impact factor: 79.321
Authors: J Ricardo Carhuapoma; Ryan J Barrett; Penelope M Keyl; Daniel F Hanley; Robert R Johnson Journal: Neurocrit Care Date: 2008 Impact factor: 3.210
Authors: Daniel F Hanley; Richard E Thompson; John Muschelli; Michael Rosenblum; Nichol McBee; Karen Lane; Amanda J Bistran-Hall; Steven W Mayo; Penelope Keyl; Dheeraj Gandhi; Tim C Morgan; Natalie Ullman; W Andrew Mould; J Ricardo Carhuapoma; Carlos Kase; Wendy Ziai; Carol B Thompson; Gayane Yenokyan; Emily Huang; William C Broaddus; R Scott Graham; E Francois Aldrich; Robert Dodd; Cristanne Wijman; Jean-Louis Caron; Judy Huang; Paul Camarata; A David Mendelow; Barbara Gregson; Scott Janis; Paul Vespa; Neil Martin; Issam Awad; Mario Zuccarello Journal: Lancet Neurol Date: 2016-10-11 Impact factor: 44.182